nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—thyroid cancer	0.443	1	CbGaD
Ketoprofen—ABCC4—Sorafenib—thyroid cancer	0.135	0.476	CbGbCtD
Ketoprofen—ALB—Vandetanib—thyroid cancer	0.0828	0.293	CbGbCtD
Ketoprofen—CYP2C8—Sorafenib—thyroid cancer	0.0386	0.136	CbGbCtD
Ketoprofen—CYP2C9—Sorafenib—thyroid cancer	0.0269	0.0951	CbGbCtD
Ketoprofen—Ketorolac—PTGS2—thyroid cancer	0.000696	0.109	CrCbGaD
Ketoprofen—Carprofen—PTGS2—thyroid cancer	0.000696	0.109	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—thyroid cancer	0.000668	0.105	CrCbGaD
Ketoprofen—Abdominal pain—Vandetanib—thyroid cancer	0.000568	0.00315	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS2—thyroid cancer	0.000568	0.0889	CrCbGaD
Ketoprofen—Skin discolouration—Epirubicin—thyroid cancer	0.000556	0.00308	CcSEcCtD
Ketoprofen—Rectal haemorrhage—Epirubicin—thyroid cancer	0.000556	0.00308	CcSEcCtD
Ketoprofen—Anaemia—Sorafenib—thyroid cancer	0.000549	0.00304	CcSEcCtD
Ketoprofen—Angioedema—Sorafenib—thyroid cancer	0.000542	0.00301	CcSEcCtD
Ketoprofen—Nepafenac—PTGS2—thyroid cancer	0.00054	0.0846	CrCbGaD
Ketoprofen—Vasodilation—Doxorubicin—thyroid cancer	0.000528	0.00293	CcSEcCtD
Ketoprofen—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000528	0.00293	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS2—thyroid cancer	0.000528	0.0827	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—thyroid cancer	0.000517	0.0809	CrCbGaD
Ketoprofen—Asthenia—Vandetanib—thyroid cancer	0.000515	0.00286	CcSEcCtD
Ketoprofen—Skin discolouration—Doxorubicin—thyroid cancer	0.000514	0.00285	CcSEcCtD
Ketoprofen—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.000514	0.00285	CcSEcCtD
Ketoprofen—Hypertension—Sorafenib—thyroid cancer	0.000513	0.00284	CcSEcCtD
Ketoprofen—Pruritus—Vandetanib—thyroid cancer	0.000508	0.00282	CcSEcCtD
Ketoprofen—Myalgia—Sorafenib—thyroid cancer	0.000505	0.0028	CcSEcCtD
Ketoprofen—Dry mouth—Sorafenib—thyroid cancer	0.000494	0.00274	CcSEcCtD
Ketoprofen—Eructation—Epirubicin—thyroid cancer	0.000493	0.00273	CcSEcCtD
Ketoprofen—Diarrhoea—Vandetanib—thyroid cancer	0.000491	0.00272	CcSEcCtD
Ketoprofen—Melaena—Epirubicin—thyroid cancer	0.00049	0.00272	CcSEcCtD
Ketoprofen—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000487	0.0027	CcSEcCtD
Ketoprofen—Anaphylactic shock—Sorafenib—thyroid cancer	0.000484	0.00268	CcSEcCtD
Ketoprofen—Colitis—Epirubicin—thyroid cancer	0.000482	0.00267	CcSEcCtD
Ketoprofen—Infection—Sorafenib—thyroid cancer	0.000481	0.00267	CcSEcCtD
Ketoprofen—Shock—Sorafenib—thyroid cancer	0.000477	0.00264	CcSEcCtD
Ketoprofen—Dizziness—Vandetanib—thyroid cancer	0.000475	0.00263	CcSEcCtD
Ketoprofen—Thrombocytopenia—Sorafenib—thyroid cancer	0.000474	0.00263	CcSEcCtD
Ketoprofen—Blood urea increased—Epirubicin—thyroid cancer	0.000474	0.00263	CcSEcCtD
Ketoprofen—Aplastic anaemia—Epirubicin—thyroid cancer	0.000471	0.00261	CcSEcCtD
Ketoprofen—Anorexia—Sorafenib—thyroid cancer	0.000462	0.00256	CcSEcCtD
Ketoprofen—Vomiting—Vandetanib—thyroid cancer	0.000457	0.00253	CcSEcCtD
Ketoprofen—Eructation—Doxorubicin—thyroid cancer	0.000456	0.00253	CcSEcCtD
Ketoprofen—Mouth ulceration—Epirubicin—thyroid cancer	0.000454	0.00251	CcSEcCtD
Ketoprofen—Melaena—Doxorubicin—thyroid cancer	0.000454	0.00251	CcSEcCtD
Ketoprofen—Rash—Vandetanib—thyroid cancer	0.000453	0.00251	CcSEcCtD
Ketoprofen—Dermatitis—Vandetanib—thyroid cancer	0.000452	0.00251	CcSEcCtD
Ketoprofen—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000451	0.0025	CcSEcCtD
Ketoprofen—Headache—Vandetanib—thyroid cancer	0.00045	0.00249	CcSEcCtD
Ketoprofen—Salsalate—PTGS2—thyroid cancer	0.000449	0.0703	CrCbGaD
Ketoprofen—Colitis—Doxorubicin—thyroid cancer	0.000446	0.00247	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000441	0.00245	CcSEcCtD
Ketoprofen—Blood urea increased—Doxorubicin—thyroid cancer	0.000438	0.00243	CcSEcCtD
Ketoprofen—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000436	0.00242	CcSEcCtD
Ketoprofen—Sepsis—Epirubicin—thyroid cancer	0.000435	0.00241	CcSEcCtD
Ketoprofen—Dyspnoea—Sorafenib—thyroid cancer	0.000432	0.00239	CcSEcCtD
Ketoprofen—Suprofen—PTGS2—thyroid cancer	0.00043	0.0674	CrCbGaD
Ketoprofen—Nausea—Vandetanib—thyroid cancer	0.000427	0.00236	CcSEcCtD
Ketoprofen—Dyspepsia—Sorafenib—thyroid cancer	0.000426	0.00236	CcSEcCtD
Ketoprofen—Decreased appetite—Sorafenib—thyroid cancer	0.000421	0.00233	CcSEcCtD
Ketoprofen—Mouth ulceration—Doxorubicin—thyroid cancer	0.00042	0.00233	CcSEcCtD
Ketoprofen—Diabetes mellitus—Epirubicin—thyroid cancer	0.000419	0.00232	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000418	0.00232	CcSEcCtD
Ketoprofen—Fatigue—Sorafenib—thyroid cancer	0.000418	0.00231	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000417	0.00231	CcSEcCtD
Ketoprofen—Photosensitivity—Epirubicin—thyroid cancer	0.000415	0.0023	CcSEcCtD
Ketoprofen—Constipation—Sorafenib—thyroid cancer	0.000414	0.0023	CcSEcCtD
Ketoprofen—Vascular purpura—Epirubicin—thyroid cancer	0.000407	0.00226	CcSEcCtD
Ketoprofen—Eczema—Epirubicin—thyroid cancer	0.000405	0.00225	CcSEcCtD
Ketoprofen—Eye pain—Epirubicin—thyroid cancer	0.000404	0.00224	CcSEcCtD
Ketoprofen—Sepsis—Doxorubicin—thyroid cancer	0.000403	0.00223	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000402	0.00223	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000396	0.0022	CcSEcCtD
Ketoprofen—Increased appetite—Epirubicin—thyroid cancer	0.000388	0.00215	CcSEcCtD
Ketoprofen—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000388	0.00215	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000386	0.00214	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000386	0.00214	CcSEcCtD
Ketoprofen—Urticaria—Sorafenib—thyroid cancer	0.000385	0.00213	CcSEcCtD
Ketoprofen—Photosensitivity—Doxorubicin—thyroid cancer	0.000384	0.00213	CcSEcCtD
Ketoprofen—Abdominal pain—Sorafenib—thyroid cancer	0.000383	0.00212	CcSEcCtD
Ketoprofen—Renal impairment—Epirubicin—thyroid cancer	0.000383	0.00212	CcSEcCtD
Ketoprofen—Dermatitis bullous—Epirubicin—thyroid cancer	0.000381	0.00211	CcSEcCtD
Ketoprofen—Purpura—Epirubicin—thyroid cancer	0.000378	0.00209	CcSEcCtD
Ketoprofen—Vascular purpura—Doxorubicin—thyroid cancer	0.000377	0.00209	CcSEcCtD
Ketoprofen—Eczema—Doxorubicin—thyroid cancer	0.000375	0.00208	CcSEcCtD
Ketoprofen—Eye pain—Doxorubicin—thyroid cancer	0.000373	0.00207	CcSEcCtD
Ketoprofen—Cardiac failure—Epirubicin—thyroid cancer	0.000373	0.00207	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000372	0.00206	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS2—thyroid cancer	0.000371	0.0581	CrCbGaD
Ketoprofen—Hyponatraemia—Epirubicin—thyroid cancer	0.000366	0.00203	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000364	0.00202	CcSEcCtD
Ketoprofen—Increased appetite—Doxorubicin—thyroid cancer	0.000359	0.00199	CcSEcCtD
Ketoprofen—Migraine—Epirubicin—thyroid cancer	0.000359	0.00199	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000357	0.00198	CcSEcCtD
Ketoprofen—Hypersensitivity—Sorafenib—thyroid cancer	0.000357	0.00198	CcSEcCtD
Ketoprofen—Renal impairment—Doxorubicin—thyroid cancer	0.000354	0.00196	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000353	0.00195	CcSEcCtD
Ketoprofen—Face oedema—Epirubicin—thyroid cancer	0.000352	0.00195	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—thyroid cancer	0.00035	0.00194	CcSEcCtD
Ketoprofen—Asthenia—Sorafenib—thyroid cancer	0.000348	0.00193	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—thyroid cancer	0.000345	0.00191	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—thyroid cancer	0.000344	0.0539	CrCbGaD
Ketoprofen—Pruritus—Sorafenib—thyroid cancer	0.000343	0.0019	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—thyroid cancer	0.000338	0.00188	CcSEcCtD
Ketoprofen—Naproxen—PTGS2—thyroid cancer	0.000338	0.0529	CrCbGaD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000337	0.00187	CcSEcCtD
Ketoprofen—Abdominal pain upper—Epirubicin—thyroid cancer	0.000333	0.00184	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—thyroid cancer	0.000332	0.00184	CcSEcCtD
Ketoprofen—Diarrhoea—Sorafenib—thyroid cancer	0.000331	0.00184	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000328	0.00182	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—thyroid cancer	0.000325	0.0018	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—thyroid cancer	0.000322	0.00179	CcSEcCtD
Ketoprofen—Dizziness—Sorafenib—thyroid cancer	0.00032	0.00178	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—thyroid cancer	0.000315	0.00174	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—thyroid cancer	0.000309	0.00171	CcSEcCtD
Ketoprofen—Vomiting—Sorafenib—thyroid cancer	0.000308	0.00171	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000308	0.00171	CcSEcCtD
Ketoprofen—Rash—Sorafenib—thyroid cancer	0.000305	0.00169	CcSEcCtD
Ketoprofen—Dermatitis—Sorafenib—thyroid cancer	0.000305	0.00169	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000304	0.00168	CcSEcCtD
Ketoprofen—Headache—Sorafenib—thyroid cancer	0.000304	0.00168	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—thyroid cancer	0.000298	0.00165	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—thyroid cancer	0.000291	0.00161	CcSEcCtD
Ketoprofen—Nausea—Sorafenib—thyroid cancer	0.000288	0.00159	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000287	0.00159	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—thyroid cancer	0.000287	0.00159	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—thyroid cancer	0.000286	0.00158	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—thyroid cancer	0.000285	0.00158	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—thyroid cancer	0.000281	0.00156	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000278	0.00154	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—thyroid cancer	0.000276	0.00153	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—thyroid cancer	0.000274	0.00152	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—thyroid cancer	0.000274	0.00152	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—thyroid cancer	0.000273	0.00151	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—thyroid cancer	0.000269	0.00149	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—thyroid cancer	0.000268	0.00148	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000266	0.00147	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—thyroid cancer	0.000265	0.00147	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—thyroid cancer	0.000265	0.00147	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—thyroid cancer	0.000264	0.00146	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—thyroid cancer	0.000262	0.00145	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—thyroid cancer	0.00026	0.00144	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000258	0.00143	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—thyroid cancer	0.000255	0.00141	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—thyroid cancer	0.000253	0.0014	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—thyroid cancer	0.000253	0.0014	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—thyroid cancer	0.000253	0.0014	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—thyroid cancer	0.000252	0.0014	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—thyroid cancer	0.000252	0.0014	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—thyroid cancer	0.00025	0.00139	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—thyroid cancer	0.000249	0.00138	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—thyroid cancer	0.000248	0.00137	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—thyroid cancer	0.000245	0.00136	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—thyroid cancer	0.000243	0.00135	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—thyroid cancer	0.000242	0.00134	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—thyroid cancer	0.000242	0.0379	CrCbGaD
Ketoprofen—Erythema multiforme—Epirubicin—thyroid cancer	0.000238	0.00132	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—thyroid cancer	0.000235	0.0013	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—thyroid cancer	0.000234	0.0013	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—thyroid cancer	0.000234	0.0013	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—thyroid cancer	0.000233	0.00129	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—thyroid cancer	0.000231	0.00128	CcSEcCtD
Ketoprofen—Chills—Epirubicin—thyroid cancer	0.000226	0.00125	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—thyroid cancer	0.000225	0.00125	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—thyroid cancer	0.000225	0.00125	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—thyroid cancer	0.000223	0.00123	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—thyroid cancer	0.00022	0.00122	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—thyroid cancer	0.000219	0.00122	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—thyroid cancer	0.000217	0.0012	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—thyroid cancer	0.000216	0.0012	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—thyroid cancer	0.000216	0.0012	CcSEcCtD
Ketoprofen—Tension—Epirubicin—thyroid cancer	0.000215	0.00119	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—thyroid cancer	0.000215	0.00119	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—thyroid cancer	0.000213	0.00118	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—thyroid cancer	0.000209	0.00116	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—thyroid cancer	0.000208	0.00115	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—thyroid cancer	0.000206	0.00114	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—thyroid cancer	0.000204	0.00113	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—thyroid cancer	0.000203	0.00112	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—thyroid cancer	0.000203	0.00112	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—thyroid cancer	0.0002	0.00111	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—thyroid cancer	0.000199	0.0011	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—thyroid cancer	0.000199	0.0011	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—thyroid cancer	0.000198	0.0011	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—thyroid cancer	0.000197	0.00109	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—thyroid cancer	0.000197	0.00109	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—thyroid cancer	0.000194	0.00107	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—thyroid cancer	0.00019	0.00105	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—thyroid cancer	0.000189	0.00105	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000188	0.00104	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—thyroid cancer	0.000188	0.00104	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—thyroid cancer	0.000187	0.00104	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—thyroid cancer	0.000186	0.00103	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—thyroid cancer	0.000185	0.00102	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—thyroid cancer	0.000183	0.00101	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—thyroid cancer	0.000183	0.00101	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—thyroid cancer	0.000182	0.00101	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—thyroid cancer	0.000181	0.001	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—thyroid cancer	0.000179	0.000994	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—thyroid cancer	0.000179	0.000992	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—thyroid cancer	0.000179	0.000992	CcSEcCtD
Ketoprofen—Infection—Epirubicin—thyroid cancer	0.000178	0.000986	CcSEcCtD
Ketoprofen—Shock—Epirubicin—thyroid cancer	0.000176	0.000976	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—thyroid cancer	0.000176	0.000975	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—thyroid cancer	0.000175	0.000971	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—thyroid cancer	0.000175	0.000971	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—thyroid cancer	0.000175	0.000968	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—thyroid cancer	0.000173	0.000959	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—thyroid cancer	0.000173	0.000958	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—thyroid cancer	0.000172	0.000954	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—thyroid cancer	0.000171	0.000946	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—thyroid cancer	0.000171	0.000946	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—thyroid cancer	0.000169	0.000937	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—thyroid cancer	0.000167	0.000926	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—thyroid cancer	0.000166	0.000918	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000166	0.000918	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—thyroid cancer	0.000165	0.000912	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000163	0.000904	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—thyroid cancer	0.000163	0.000903	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000162	0.000899	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—thyroid cancer	0.000162	0.000897	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—thyroid cancer	0.000162	0.000896	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—thyroid cancer	0.000161	0.000891	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00016	0.000888	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—thyroid cancer	0.00016	0.000885	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—thyroid cancer	0.000159	0.000882	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—thyroid cancer	0.000158	0.000875	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—thyroid cancer	0.000158	0.000873	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—thyroid cancer	0.000156	0.000863	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000155	0.000857	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—thyroid cancer	0.000154	0.000855	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—thyroid cancer	0.000153	0.000848	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000151	0.000836	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—thyroid cancer	0.00015	0.00083	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—thyroid cancer	0.000149	0.000824	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—thyroid cancer	0.000148	0.000818	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—thyroid cancer	0.000148	0.000818	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—thyroid cancer	0.000147	0.000816	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000146	0.000811	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—thyroid cancer	0.000146	0.000808	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—thyroid cancer	0.000144	0.000798	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000143	0.000793	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—thyroid cancer	0.000143	0.000792	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—thyroid cancer	0.000142	0.000788	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—thyroid cancer	0.000142	0.000785	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—thyroid cancer	0.000142	0.000784	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—thyroid cancer	0.000137	0.000757	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000135	0.000751	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000132	0.00152	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Epirubicin—thyroid cancer	0.000132	0.000731	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—thyroid cancer	0.000132	0.000729	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—thyroid cancer	0.000131	0.000726	CcSEcCtD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000129	0.00149	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000129	0.00148	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000129	0.00148	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MEN1—thyroid cancer	0.000129	0.00148	CbGpPWpGaD
Ketoprofen—Asthenia—Epirubicin—thyroid cancer	0.000128	0.000712	CcSEcCtD
Ketoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000127	0.00147	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000127	0.00146	CbGpPWpGaD
Ketoprofen—Pruritus—Epirubicin—thyroid cancer	0.000127	0.000702	CcSEcCtD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000126	0.00146	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TRIM33—thyroid cancer	0.000126	0.00146	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000126	0.00146	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000126	0.00145	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000123	0.00141	CbGpPWpGaD
Ketoprofen—Diarrhoea—Epirubicin—thyroid cancer	0.000123	0.000679	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—thyroid cancer	0.000122	0.000676	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000121	0.0014	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—thyroid cancer	0.000119	0.00137	CbGpPWpGaD
Ketoprofen—Asthenia—Doxorubicin—thyroid cancer	0.000119	0.000659	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—thyroid cancer	0.000118	0.000656	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—thyroid cancer	0.000117	0.00065	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—PTCH1—thyroid cancer	0.000116	0.00134	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000116	0.00133	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—TSHR—thyroid cancer	0.000115	0.00133	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000115	0.00132	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000114	0.00132	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000114	0.00132	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—thyroid cancer	0.000114	0.00131	CbGpPWpGaD
Ketoprofen—Vomiting—Epirubicin—thyroid cancer	0.000114	0.000631	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000114	0.00131	CbGpPWpGaD
Ketoprofen—Diarrhoea—Doxorubicin—thyroid cancer	0.000113	0.000628	CcSEcCtD
Ketoprofen—Rash—Epirubicin—thyroid cancer	0.000113	0.000626	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—thyroid cancer	0.000113	0.000625	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000113	0.0013	CbGpPWpGaD
Ketoprofen—Headache—Epirubicin—thyroid cancer	0.000112	0.000622	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000112	0.00129	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MINPP1—thyroid cancer	0.00011	0.00127	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00011	0.00127	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00011	0.00127	CbGpPWpGaD
Ketoprofen—Dizziness—Doxorubicin—thyroid cancer	0.00011	0.000607	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000109	0.00126	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—thyroid cancer	0.000109	0.00125	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000107	0.00124	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000107	0.00124	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SST—thyroid cancer	0.000106	0.00123	CbGpPWpGaD
Ketoprofen—Nausea—Epirubicin—thyroid cancer	0.000106	0.000589	CcSEcCtD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000106	0.00122	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000106	0.00122	CbGpPWpGaD
Ketoprofen—Vomiting—Doxorubicin—thyroid cancer	0.000105	0.000584	CcSEcCtD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000105	0.00121	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—TSHR—thyroid cancer	0.000105	0.0012	CbGpPWpGaD
Ketoprofen—Rash—Doxorubicin—thyroid cancer	0.000104	0.000579	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—thyroid cancer	0.000104	0.000578	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—thyroid cancer	0.000104	0.000575	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000103	0.00119	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000103	0.00118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000103	0.00118	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CALCA—thyroid cancer	0.000102	0.00118	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000102	0.00118	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—thyroid cancer	9.84e-05	0.000545	CcSEcCtD
Ketoprofen—CYP2C8—Biological oxidations—RXRA—thyroid cancer	9.68e-05	0.00111	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.66e-05	0.00111	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.64e-05	0.00111	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.64e-05	0.00111	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	9.47e-05	0.00109	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NDUFA13—thyroid cancer	9.36e-05	0.00108	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—HPGD—thyroid cancer	9.33e-05	0.00107	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IFNA2—thyroid cancer	9.3e-05	0.00107	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDK1—thyroid cancer	9.27e-05	0.00107	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.24e-05	0.00106	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—SST—thyroid cancer	8.95e-05	0.00103	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PTCH1—thyroid cancer	8.89e-05	0.00102	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TRIM24—thyroid cancer	8.87e-05	0.00102	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CHST14—thyroid cancer	8.8e-05	0.00101	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MINPP1—thyroid cancer	8.74e-05	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CALCA—thyroid cancer	8.62e-05	0.000992	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.56e-05	0.000986	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TCF7L1—thyroid cancer	8.44e-05	0.000971	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.37e-05	0.000964	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CHST14—thyroid cancer	8.34e-05	0.000961	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	8.23e-05	0.000948	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	8.17e-05	0.000941	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	8.16e-05	0.000939	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—SST—thyroid cancer	8.13e-05	0.000936	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.1e-05	0.000933	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.05e-05	0.000927	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	8.04e-05	0.000926	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TRIM33—thyroid cancer	7.91e-05	0.000911	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—RXRA—thyroid cancer	7.88e-05	0.000907	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CALCA—thyroid cancer	7.82e-05	0.000901	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.77e-05	0.000894	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.56e-05	0.000871	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—thyroid cancer	7.54e-05	0.000868	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRG1—thyroid cancer	7.44e-05	0.000857	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NDUFA13—thyroid cancer	7.43e-05	0.000856	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	7.22e-05	0.000831	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.19e-05	0.000828	CbGpPWpGaD
Ketoprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	7.15e-05	0.000823	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MINPP1—thyroid cancer	7.11e-05	0.000819	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HPGD—thyroid cancer	7.09e-05	0.000817	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CDK1—thyroid cancer	7.08e-05	0.000816	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MINPP1—thyroid cancer	7.07e-05	0.000814	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	7.02e-05	0.000808	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CHST14—thyroid cancer	6.99e-05	0.000805	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.76e-05	0.000778	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TERT—thyroid cancer	6.68e-05	0.000769	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HIF1A—thyroid cancer	6.39e-05	0.000736	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PRKAR1A—thyroid cancer	6.35e-05	0.000731	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TSHR—thyroid cancer	6.17e-05	0.000711	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—thyroid cancer	6.12e-05	0.000705	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PRKAR1A—thyroid cancer	6.07e-05	0.000699	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NDUFA13—thyroid cancer	6.05e-05	0.000696	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NDUFA13—thyroid cancer	6.01e-05	0.000692	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	5.97e-05	0.000687	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MEN1—thyroid cancer	5.8e-05	0.000668	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MINPP1—thyroid cancer	5.79e-05	0.000666	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.75e-05	0.000663	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—thyroid cancer	5.7e-05	0.000656	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CHST14—thyroid cancer	5.68e-05	0.000655	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CHST14—thyroid cancer	5.65e-05	0.000651	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HPGD—thyroid cancer	5.63e-05	0.000649	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—NRAS—thyroid cancer	5.63e-05	0.000648	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	5.59e-05	0.000643	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	5.59e-05	0.000643	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.5e-05	0.000633	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TPR—thyroid cancer	5.36e-05	0.000617	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—BRAF—thyroid cancer	5.29e-05	0.000609	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TCF7L1—thyroid cancer	5.28e-05	0.000608	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	5.27e-05	0.000607	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTCH1—thyroid cancer	5.25e-05	0.000605	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.92e-05	0.000567	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.91e-05	0.000565	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—KRAS—thyroid cancer	4.84e-05	0.000558	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SST—thyroid cancer	4.8e-05	0.000553	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.78e-05	0.00055	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	4.75e-05	0.000547	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.74e-05	0.000546	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CHST14—thyroid cancer	4.63e-05	0.000533	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CALCA—thyroid cancer	4.62e-05	0.000532	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HPGD—thyroid cancer	4.58e-05	0.000528	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.57e-05	0.000526	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HPGD—thyroid cancer	4.56e-05	0.000525	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.34e-05	0.0005	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IFNA2—thyroid cancer	4.21e-05	0.000484	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDK1—thyroid cancer	4.18e-05	0.000482	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.18e-05	0.000482	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—thyroid cancer	4.12e-05	0.000474	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TPR—thyroid cancer	4.07e-05	0.000469	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	4.01e-05	0.000462	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.01e-05	0.000462	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AKT1—thyroid cancer	4e-05	0.000461	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TPR—thyroid cancer	3.86e-05	0.000445	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—thyroid cancer	3.86e-05	0.000445	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PRKAR1A—thyroid cancer	3.8e-05	0.000438	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.76e-05	0.000433	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HPGD—thyroid cancer	3.73e-05	0.000429	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTEN—thyroid cancer	3.73e-05	0.000429	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.72e-05	0.000428	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.7e-05	0.000426	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.64e-05	0.000419	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—thyroid cancer	3.64e-05	0.000419	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.63e-05	0.000418	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MEN1—thyroid cancer	3.63e-05	0.000418	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.51e-05	0.000405	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—thyroid cancer	3.47e-05	0.000399	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—RXRA—thyroid cancer	3.37e-05	0.000388	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRG1—thyroid cancer	3.36e-05	0.000387	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—thyroid cancer	3.33e-05	0.000383	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.28e-05	0.000377	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TPR—thyroid cancer	3.23e-05	0.000372	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.23e-05	0.000372	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PRKAR1A—thyroid cancer	3.18e-05	0.000366	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.05e-05	0.000351	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.03e-05	0.000348	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TERT—thyroid cancer	3.02e-05	0.000347	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—thyroid cancer	2.98e-05	0.000344	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CALCA—thyroid cancer	2.89e-05	0.000333	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.88e-05	0.000332	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HIF1A—thyroid cancer	2.88e-05	0.000332	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—thyroid cancer	2.86e-05	0.00033	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.86e-05	0.000329	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.73e-05	0.000314	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—thyroid cancer	2.65e-05	0.000305	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TPR—thyroid cancer	2.63e-05	0.000303	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDK1—thyroid cancer	2.62e-05	0.000301	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TPR—thyroid cancer	2.62e-05	0.000301	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.59e-05	0.000298	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PRKAR1A—thyroid cancer	2.57e-05	0.000296	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—RXRA—thyroid cancer	2.56e-05	0.000295	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—thyroid cancer	2.54e-05	0.000293	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—thyroid cancer	2.54e-05	0.000293	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—thyroid cancer	2.54e-05	0.000292	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.49e-05	0.000287	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—thyroid cancer	2.43e-05	0.00028	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—thyroid cancer	2.42e-05	0.000279	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BRAF—thyroid cancer	2.39e-05	0.000275	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.35e-05	0.00027	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.33e-05	0.000269	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—thyroid cancer	2.24e-05	0.000258	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—thyroid cancer	2.19e-05	0.000252	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—thyroid cancer	2.15e-05	0.000247	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TPR—thyroid cancer	2.14e-05	0.000247	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—thyroid cancer	2.13e-05	0.000245	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.11e-05	0.000243	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRG1—thyroid cancer	2.1e-05	0.000242	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—RXRA—thyroid cancer	2.03e-05	0.000234	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.98e-05	0.000228	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.97e-05	0.000227	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.97e-05	0.000226	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—thyroid cancer	1.96e-05	0.000226	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.91e-05	0.00022	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—thyroid cancer	1.89e-05	0.000217	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—thyroid cancer	1.86e-05	0.000214	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.85e-05	0.000213	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.84e-05	0.000211	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—thyroid cancer	1.81e-05	0.000208	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—thyroid cancer	1.8e-05	0.000208	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—thyroid cancer	1.74e-05	0.000201	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—thyroid cancer	1.68e-05	0.000194	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.67e-05	0.000193	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—RXRA—thyroid cancer	1.66e-05	0.000191	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—RXRA—thyroid cancer	1.65e-05	0.00019	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—thyroid cancer	1.64e-05	0.000189	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—thyroid cancer	1.62e-05	0.000186	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.61e-05	0.000185	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.6e-05	0.000185	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.6e-05	0.000184	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—thyroid cancer	1.57e-05	0.000181	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.5e-05	0.000173	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—thyroid cancer	1.5e-05	0.000173	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BRAF—thyroid cancer	1.49e-05	0.000172	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.46e-05	0.000168	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—thyroid cancer	1.35e-05	0.000155	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—RXRA—thyroid cancer	1.35e-05	0.000155	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.31e-05	0.000151	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—thyroid cancer	1.29e-05	0.000149	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—thyroid cancer	1.28e-05	0.000148	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—thyroid cancer	1.27e-05	0.000147	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—thyroid cancer	1.2e-05	0.000138	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—thyroid cancer	1.15e-05	0.000132	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—thyroid cancer	1.15e-05	0.000132	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—thyroid cancer	1.11e-05	0.000128	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—thyroid cancer	1.1e-05	0.000126	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—thyroid cancer	1.05e-05	0.000121	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—thyroid cancer	1.05e-05	0.00012	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—thyroid cancer	1.04e-05	0.00012	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—thyroid cancer	1.01e-05	0.000117	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—thyroid cancer	9.69e-06	0.000112	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—thyroid cancer	9.39e-06	0.000108	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—thyroid cancer	8.81e-06	0.000101	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—thyroid cancer	8.51e-06	9.8e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—thyroid cancer	8.41e-06	9.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—thyroid cancer	8.22e-06	9.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—thyroid cancer	8.17e-06	9.41e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—thyroid cancer	8.08e-06	9.3e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—thyroid cancer	7.17e-06	8.26e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—thyroid cancer	7.13e-06	8.21e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—thyroid cancer	6.87e-06	7.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—thyroid cancer	6.69e-06	7.71e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—thyroid cancer	6.4e-06	7.37e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—thyroid cancer	6.06e-06	6.98e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—thyroid cancer	5.84e-06	6.72e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—thyroid cancer	5.08e-06	5.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—thyroid cancer	4.13e-06	4.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—thyroid cancer	4.11e-06	4.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—thyroid cancer	3.36e-06	3.87e-05	CbGpPWpGaD
